QSAR as a random event: a case of NOAEL

Environmental Science and Pollution Research

Volumn 22, Issue 11, 2015, Pages 8264-8271

  Toropova, Alla P ^a   Toropov, Andrey A ^a   Veselinović, Jovana B ^b   Veselinović, Aleksandar M ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

Chronic toxicity; Monte Carlo technique; NOAEL; Optimal descriptor; QSAR

Indexed keywords

MODEL VALIDATION; MOLECULAR ANALYSIS; MONTE CARLO ANALYSIS; OPTIMIZATION; QUANTITATIVE ANALYSIS; TOXICITY;

POLLUTANT;

CALIBRATION; CHEMICAL STRUCTURE; CHEMISTRY; MONTE CARLO METHOD; NO-OBSERVED-ADVERSE-EFFECT LEVEL; POLLUTANT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; THEORETICAL MODEL; TOXICITY;

CALIBRATION; ENVIRONMENTAL POLLUTANTS; MODELS, THEORETICAL; MOLECULAR STRUCTURE; MONTE CARLO METHOD; NO-OBSERVED-ADVERSE-EFFECT LEVEL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84929842142     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-014-3977-2     Document Type: Article

References (35)

1. Afantitis A, Melagraki G, Koutentis PA, Sarimveis H, Kollias G (2011) Ligand-based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks. Eur J Med Chem 46(2):497–508
2. Contrera JF, Matthews EJ, Kruhlak NL, Benz RD (2004) Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. Regul Toxicol Pharm 40(3):185–206
3. Dobchev DA, Tulp I, Karelson G, Tamm T, Tämma K, Karelson M (2013) Subchronic oral and inhalation toxicities: a challenging attempt for modeling and prediction. Mol Inf 32(9–10):793–801
4. Furtula B, Gutman I (2011) Relation between second and third geometric-arithmetic indices of trees. J Chemometr 25(2):87–91
5. Gajewska M, Worth A, Urani C, Briesen H, Schramm K-W (2014) Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients. Toxicol Lett 227(3):189–202
6. García J, Duchowicz PR, Rozas MF, Caram JA, Mirífico MV, Fernández FM, Castro EA (2011) A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases. J Mol Graph Model 31:10–19
7. Garro-Martinez JC, Duchowicz PR, Estrada MR, Zamarbide GN, Castro EA (2011) QSAR study and molecular design of open-chain enaminones as anticonvulsant agents. Int J Mol Sci 12(12):9354–9368
8. Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20(4):269–276
9. Goto, T., 2013. QSAR modeling using a set of intermediate-duration oral NOELs (2013), PhD thesis, https://etd.library.emory.edu/view/record/pid/emory:d724n
10. Ibezim E, Duchowicz PR, Ortiz EV, Castro EA (2012) QSAR on aryl-piperazine derivatives with activity on malaria. Chemometr Intell Lab Syst 110(1):81–88
11. Lewis RW, Billington R, Debryune E, Gamer A, Lang B, Carpanini F (2002) Recognition of adverse and nonadverse effects in toxicity studies. Toxicol Path 30(1):66–74
12. Mazzatorta P, Estevez MD, Coulet M, Schilter B (2008) Modeling oral rat chronic toxicity. J Chem Inf Model 48(10):1949–1954
13. Mullen LMA, Duchowicz PR, Castro EA (2011) QSAR treatment on a new class of triphenylmethyl-containing compounds as potent anticancer agents. Chemometr Intell Lab Syst 107(2):269–275
14. Nesmerak K, Toropov AA, Toropova AP, Kohoutova P, Waisser K (2013) SMILES-based quantitative structure-property relationships for half-wave potential of N-benzylsalicylthioamides. Eur J Med Chem 67:111–114
15. OECD, 2007, Guidance document on the validation of (quantitative) structure-activity relationships [(Q)Sar] models, http://www.oecd.org/dataoecd/55/35/38130292.pdf
16. Ojha PK, Roy K (2011) Comparative QSARs for antimalarial endochins: importance of descriptor-thinning and noise reduction prior to feature selection. Chemometr Intell Lab Syst 109(2):146–161
17. Parasuraman S (2011) Toxicological screening. J Pharmacol Pharmacoth 2(2):74–79
18. Park Y-C, Cho M-H (2011) A new way in deciding NOAEL based on the findings from GLP-toxicity test. Toxicol Res 27(3):133–135
19. Roy K, Mitra I (2012) Electrotopological state atom (E-state) index in drug design, QSAR, property prediction and toxicity assessment. Curr Comput-Aid Drug Des 8(2):135–158
20. Roy PP, Leonard JT, Roy K (2008) Exploring the impact of size of training sets for the development of predictive QSAR models. Chemometr Intell Lab Syst 90(1):31–42
21. 2 (rank) metric incorporating rank-order predictions as an additional tool for validation of QSAR/QSPR models. Chemometr Intell Lab Syst 118:200–210
22. Roy K, Mitra I, Kar S, Ojha PK, Das RN, Kabir H (2012b) Comparative studies on some metrics for external validation of QSPR models. J Chem Inf Model 52(2):396–408
23. Rupp B, Appel KE, Gundert-Remy U (2010) Chronic oral LOAEL prediction by using a commercially available computational QSAR tool. Arch Toxicol 84(9):681–688
24. Toropov AA, Toropova AP, Benfenati E (2009) QSPR modeling bioconcentration factor (BCF) by balance of correlations. Eur J Med Chem 44(6):2544–2551
25. Toropov AA, Toropova AP, Puzyn T, Benfenati E, Gini G, Leszczynska D, Leszczynski J (2013) QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells. Chemosphere 92(1):31–37
26. Toropova AP, Toropov AA (2013) Optimal descriptor as a translator of eclectic information into the prediction of membrane damage by means of various TiO2 nanoparticles. Chemosphere 93(10):2650–2655
27. Toropova AP, Toropov AA (2014) CORAL software: prediction of carcinogenicity of drugs by means of the Monte Carlo method. Eur J Pharm Sci 52(1):21–25
28. Toropova AP, Toropov AA, Benfenati E, Gini G, Leszczynska D, Leszczynski J (2011) CORAL: quantitative structure-activity relationship models for estimating toxicity of organic compounds in rats. J Comput Chem 32(12):2727–2733
29. Veselinović AM, Milosavljević JB, Toropov AA, Nikolić GM (2013a) SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT1A receptor ligands using CORAL. Eur J Pharm Sci 48(3):532–541
30. Veselinović AM, Milosavljević JB, Toropov AA, Nikolić GM (2013b) SMILES-Based QSAR models for the calcium channel-antagonistic effect of 1,4-dihydropyridines. Arch Pharm 346:134–139
31. Wang Y-J, Dou J, Cross KP, Valerio LG (2011) Computational analysis for hepatic safety signals of constituents present in botanical extracts widely used by women in the United States for treatment of menopausal symptoms. Regul Toxicol Pharm 59(1):111–124
32. Weininger D (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 28:31–36
33. Weininger D (1990) Smiles. 3. Depict. Graphical depiction of chemical structures. J Chem Inf Comput Sci 30(3):237–243
34. Weininger D, Weininger A, Weininger JL (1989) SMILES. 2. Algorithm for generation of unique SMILES notation. J Chem Inf Comput Sci 29:97–101
35. Zhu H, Ye L, Richard A, Golbraikh A, Wright FA, Rusyn I, Tropsha A (2009) A novel two-step hierarchical quantitative structure-activity relationship modeling work flow for predicting acute toxicity of chemicals in rodents. Environ Health Persp 117(8):1257–1264